Kyoto, Japan

Syoichi Ishikawa


Average Co-Inventor Count = 11.6

ph-index = 3

Forward Citations = 44(Granted Patents)


Location History:

  • Osaka, JP (1995)
  • Kyoto, JP (1996 - 1999)

Company Filing History:


Years Active: 1995-1999

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Syoichi Ishikawa: Innovator in Recombinant Human Serum Albumin

Introduction

Syoichi Ishikawa is a notable inventor based in Kyoto, Japan. He has made significant contributions to the field of biotechnology, particularly in the purification of human serum albumin. His innovative approaches have led to advancements in pharmaceutical preparations.

Latest Patents

Ishikawa holds 3 patents, with his latest focusing on recombinant human serum albumin. This invention outlines a process for producing human serum albumin through gene manipulation techniques. The purification process involves a series of steps including ultrafiltration, heat treatment, acid treatment, and additional ultrafiltration. The method ensures that the final product is free from proteinous and polysaccharide contaminants, making it suitable for pharmaceutical applications.

Career Highlights

Throughout his career, Ishikawa has been associated with The Green Cross Corporation. His work has been pivotal in enhancing the quality and purity of recombinant human serum albumin, which is crucial for various medical applications. His expertise in biotechnology has positioned him as a key figure in this field.

Collaborations

Ishikawa has collaborated with notable colleagues such as Takao Ohmura and Akinori Sumi. These partnerships have fostered innovation and have contributed to the successful development of his patented processes.

Conclusion

Syoichi Ishikawa's contributions to the field of biotechnology, particularly in the purification of recombinant human serum albumin, highlight his role as an influential inventor. His work continues to impact the pharmaceutical industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…